ANTB Stock News Antriabio Inc (ANTB) 1.9000 07/26/2014 14:48

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Antriabio Inc (ANTB) 1.9000 $ANTB

AntriaBio Appoints Barry Sherman, M.D. to Its Board of Directors
Marketwire - Wed Jul 23, 6:35AM CDT
AntriaBio, Inc. (OTCQB: ANTB), a biopharmaceutical corporation focused on developing novel therapeutics to treat patients with diabetes and metabolic diseases, announced today the appointment of Barry Sherman, M.D. to its Board of Directors.

AntriaBio, Inc. - "An Update on Basal Insulins from ADA"
ACCESSWIRE - Wed Jun 25, 9:37AM CDT
New York, NY / June 25, 2014 / AntriaBio, Inc. (OTCQB: ANTB) today published a new blog post on The Chairman's Blog, written by the Company's Chairman and CEO, Mr. Nevan Elam. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.

AntriaBio Appoints C. Ronald Kahn, M.D. to Its Scientific Advisory Board
Marketwire - Mon Jun 23, 6:35AM CDT
AntriaBio, Inc. (OTCQB: ANTB), a biopharmaceutical corporation focused on developing novel therapeutics to treat patients with diabetes and metabolic diseases, announced the appointment of C. Ronald Kahn, M.D. to its Scientific Advisory Board (SAB).

AntriaBio, Inc. "The â??Smart Science' Behind AB101"
ACCESSWIRE - Wed Jun 18, 7:32AM CDT
New York, NY / June 18, 2014 / AntriaBio, Inc. (OTCQB: ANTB) today published a new blog post on The Chairman's Blog, written by the Company's Chairman and CEO, Mr. Nevan Elam. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.

AntriaBio, Inc. to Present at the Third Annual Marcum MicroCap Conference on Thursday, May 29, 2014
Marketwire - Thu May 22, 6:35AM CDT
AntriaBio, Inc. (OTCQB: ANTB) a biopharmaceutical corporation focused on developing novel therapeutics to treat patients with diabetes and metabolic disease, announced today that Nevan Elam, Chief Executive Officer, will be presenting at the Third Annual Marcum MicroCap Conference at 3:00 p.m. Eastern Time on Thursday, May 29, 2014 at the Grand Hyatt New York.

AntriaBio, Inc. Announces $10 Million Private Placement
Marketwire - Wed Apr 02, 6:35AM CDT
AntriaBio, Inc. (OTCQB: ANTB), a biopharmaceutical company focused on developing novel therapeutics for the diabetes market, announced today that in the first quarter of 2014 it raised $10 million in a series of private placement transactions (collectively, the "Financing".

AntriaBio, Inc. to Present at 26th Annual ROTH Conference
Marketwire - Thu Mar 06, 7:05AM CST
AntriaBio, Inc. (OTCQB: ANTB), a biopharmaceutical company focused on developing novel therapeutics for the diabetes market, announced today that Nevan Elam, Chairman and Chief Executive Officer is scheduled to present at the 26th Annual ROTH Conference. The conference is taking place March 9-12, 2014, at The Ritz-Carlton, Laguna Niguel, in Dana Point, CA.

AntriaBio to Present at 16th Annual BIO CEO & Investor Conference on Tuesday, February 11, 2014
Marketwire - Wed Feb 05, 7:05AM CST
AntriaBio, Inc. (OTCQB: ANTB), a biopharmaceutical company focused on developing novel therapeutics for the diabetes market, announced today that the Company will be presenting at the 16th Annual BIO CEO & Investor Conference on Tuesday, February 11, 2014 at 2:30 p.m. Eastern Time. Hosted by the Biotechnology Industry Organization (BIO), the 16th Annual BIO CEO & Investor Conference will take place February 10-11 at the Waldorf Astoria in New York City.

AntriaBio Inc concludes bridge financing to advance AB101 into clinical development for the treatment of diabetes
M2 - Fri Jan 17, 4:46AM CST
Biopharmaceutical company AntriaBio Inc (OTCQB:ANTB) reported on Thursday that it has completed a USD2.7m bridge note financing in an exempt private placement transaction with a number of accredited investors, with Paulson Investment Company Inc as the sole placement agent.

AntriaBio Announces Closing of Bridge Financing
Marketwire - Thu Jan 16, 9:07AM CST
AntriaBio, Inc. (OTCQB: ANTB), a biopharmaceutical company focused on developing novel therapeutics for the diabetes market, announced today that it has closed a $2.7 million bridge note financing (the "Bridge Financing" in an exempt private placement transaction with a number of accredited investors. Paulson Investment Company, Inc. served as the Company's sole placement agent in the transaction.

AntriaBio Granted European Patent Allowance for Method of Preparing Site-Specific Protein Conjugates
Marketwire - Wed Jul 24, 7:30AM CDT
AntriaBio, Inc. (OTCQB: ANTB) announced today that it has received an allowance from the European Patent Office for Patent Application No. 04759347.0 entitled "Method for Preparation of Site-Specific Protein Conjugates" with claims directed to the Company's lead diabetes product candidate, AB101. This patent was also allowed in Australia.

AntriaBio Initiates Effort to Raise up to $12 Million in a Private Placement
Marketwire - Mon Jul 01, 7:31AM CDT
AntriaBio, Inc. (OTCQB: ANTB), a clinical-stage biopharmaceutical company developing therapies for the treatment of diabetes, announced today that as a result of expressions of interest from potential investors, it intends to raise up to $12 million as part of a private placement of common stock.

AntriaBio Set for a Major Short Squeeze
Marketwire - Thu Mar 14, 10:50AM CDT
A handful of early investors are fighting an uphill battle after investing in shares of AntriaBio (OTCBB: ANTB), which recently swooped in to snag an intriguing lead diabetes product, AB101, after a private firm had already invested more than $100 million into the formulation, manufacturing and intellectual property development of the injectable once-a-week basal insulin solution for diabetics who are otherwise forced to take shots on a daily basis.

Once-a-Week Insulin Shot Could Help Growing Diabetes Patient Base and Spell Huge Profits for Investors
Marketwire - Fri Feb 22, 6:23AM CST
In January 2013, newly trading AntriaBio, Inc. (OTCQB: ANTB) acquired one of the most-interesting and buzzworthy assets we've seen in some time from a private company called PR Pharmaceuticals.

AntriaBio Appoints Two Industry Leaders to Its Management Team
Marketwire - Tue Feb 19, 9:38AM CST
AntriaBio, Inc. (OTCQB: ANTB) is pleased to announce the appointment, on January 31, 2013, of two new members to its management team: Nevan Elam, as AntriaBio's President and Chief Executive Officer and Sankaram Mantripragada, Ph.D., as AntriaBio's Chief Scientific Officer.

AntriaBio Announces Stock Ticker Symbol Change to ANTB
Marketwire - Fri Feb 08, 9:45AM CST
AntriaBio, Inc. ("AntriaBio" today announced that FINRA has approved a change of the Company's stock ticker symbol. Effective today, the Company's common shares will commence trading on the OTC Bulletin Board under the trading symbol "ANTB" (OTCQB: ANTB). The previous trading symbol was "FMYY" (OTCQB: FMYY).
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Epic Blue Puts $50,000 of Marketing Work to Use Locally

Updated Category News Views 176

A $50,000 pile of donated know-how can look soft on a spreadsheet, until you remember how often a small nonprofit or early-stage outfit gets ignored because it cannot afford someone to sharpen its message. Epic Blue Marketing, a women-owned firm based in Jackson, Michigan, says it provided that amount in donated and reduced-rate marketing, communications and public...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 143

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 142

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
QuidelOrtho Faces Fresh Scrutiny Over Savanna Claims

Updated Category News Views 214

A diagnostic launch can turn into a corporate migraine with frightening speed, and QuidelOrtho is staring at exactly that sort of mess. Kahn Swick & Foti said on November 20, 2026, that it has begun investigating whether QuidelOrtho officers or directors breached fiduciary duties or otherwise violated state or federal law. This is not a finding of wrongdoing. It is an...

Continue Reading
Domino's Probe Puts Franchise Disclosure Under Lens

Updated Category News Views 139

A franchisee's shuttered stores can turn cheerful unit-growth talk into a nasty accounting of credibility, and that is the uncomfortable territory Domino's now occupies. Kahn Swick & Foti has opened an investigation into whether Domino's officers and directors breached fiduciary duties or violated state or federal law. That is not a finding of misconduct. It is a legal...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 196

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
Kyverna Probe Reopens IPO Disclosure Questions for Investors

Updated Category News Views 136

Clinical-trial caveats have a nasty habit of becoming shareholder headaches years later. Kyverna Therapeutics is back in that uncomfortable zone after Kahn Swick & Foti said it has opened an investigation into whether the company’s officers and directors breached fiduciary duties or otherwise violated state or federal law. For holders of KYTX, this is not a verdict and...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 76

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
CCAPP Holiday Training Targets Seasonal Recovery Strain

Updated Category News Views 126

December cheer has a nasty habit of hiding the people barely holding themselves together. CCAPP’s upcoming virtual workshop, Hope for the Holidays: Understanding Depression, Stress & Resilience During the Holiday Season, takes that uncomfortable reality seriously rather than treating it like a seasonal footnote. For behavioral health workers supporting people in...

Continue Reading
Cottage Grove Tests Holiday Demand Across Lake Norman

Updated Category News Views 198

Flour and foot traffic make a pretty honest little scoreboard. Cottage Grove Bakery is putting itself in front of Lake Norman shoppers twice on Saturday, November 21, while also taking Thanksgiving orders and laying groundwork for 2027 workplace and school visits. This is not a public-company earnings story, and nobody should pretend a tray of scones is a quarterly...

Continue Reading

Top 5 Most Recently Viewed Articles

Breaker’s TruSend™: A Game Changer in Email Marketing

Updated Category News Views 142

Breaker’s TruSend™: A Game Changer in Email Marketing In the fast-evolving world of marketing, email continues to hold its ground as a vital communication tool. Breaker has recognized the challenges marketers face with fragmented tech stacks and has introduced TruSend™, a robust email distribution platform. This innovation streamlines the email marketing process,...

Continue Reading
DigiKey and Qorvo Collaborate to Enhance Global Distribution

Updated Category News Views 151

DigiKey and Qorvo Forge Strategic Distribution Partnership DigiKey, a prominent global distributor known for its vast selection of technical components and automation products, has entered into a vital distribution agreement with Qorvo®, a leader in connectivity and power solutions. This collaboration aims to boost the availability and delivery speed of Qorvo's...

Continue Reading
Lloyds Bank's Financial Insights for 2025: A Comprehensive Review

Updated Category News Views 345

Overview of Lloyds Bank plc's 2025 Half-Year Results Lloyds Bank plc, a prominent player in the financial services sector, has released its half-year results for 2025, demonstrating resilience and strategic agility. As a member of the Lloyds Banking Group, it continues to show its commitment to delivering value to its stakeholders and customers. Key Financial Highlights...

Continue Reading
Advansor's Latest CO2 Enclosure Solutions Revolutionize Climate Control

Updated Category News Views 97

Advansor Introduces a New Range of CO2 Enclosures Advansor, a leading name in climate solutions, has recently unveiled an innovative line of CO2 enclosures tailored for supermarkets, cold storage facilities, and industrial applications. These enclosures are designed to simplify on-site installations and offer flexible options for outdoor placement. This groundbreaking...

Continue Reading
LG Innotek's Revolutionary Automotive AP Module Enhances Mobility

Updated Category News Views 220

LG Innotek's Innovative Entry into Automotive Semiconductor Market LG Innotek has taken a significant step into the automotive semiconductor component market with the launch of its Automotive Application Processor Module (AP Module). This move comes in response to a growing demand for sophisticated automotive technologies, particularly in the realm of Advanced Driver...

Continue Reading